Citigroup Inc X Biotech Inc. Transaction History
Citigroup Inc
- $217 Billion
- Q3 2025
A detailed history of Citigroup Inc transactions in X Biotech Inc. stock. As of the latest transaction made, Citigroup Inc holds 12 shares of XBIT stock, worth $31. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 2,943
99.59%
Holding current value
$31
Previous $8,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding XBIT
# of Institutions
48Shares Held
4.02MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.13MShares$2.97 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA819KShares$2.15 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny416KShares$1.09 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V8248KShares$650,4670.0% of portfolio
-
Geode Capital Management, LLC Boston, MA222KShares$581,2810.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $79.8M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...